Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A Practical Approach to Clinical Antibiotic Stewardship in the ICU Patient with Severe Infection.1 passage
• Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.1 passage
• Acute Cellular Rejection: Is It Still Relevant?1 passage
• Acute Liver Failure.1 passage
• Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing.1 passage
• Acute Pulmonary Exacerbations in Cystic Fibrosis.1 passage
• Acute Rejection in the Modern Lung Transplant Era.1 passage
• Acute Respiratory Distress Syndrome Phenotypes.1 passage
• Acute Respiratory Distress Syndrome: Cost (Early and Long-Term).1 passage
• Acute Respiratory Distress Syndrome: Respiratory Monitoring and Pulmonary Physiology.1 passage
• Acute Respiratory Failure and Pulmonary Complications in End-Stage Liver Disease.1 passage
• Acute on Chronic Liver Failure and Immune Dysfunction: A Mimic of Sepsis.1 passage
• Adapting the ABCDEF Bundle to Meet the Needs of Patients Requiring Prolonged Mechanical Ventilation in the Long-Term Acute Care Hospital Setting: Historical Perspectives and Practical Implications.1 passage
• Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention.1 passage
• Adult Care in Cystic Fibrosis.1 passage
• Advanced Pulmonary Sarcoidosis.1 passage
• Advances and Controversies in Thoracentesis and Medical Thoracoscopy.1 passage
• Advances and Evolving Concepts in Allergic Asthma.1 passage
• Advances in the Management of Acute Venous Thromboembolism and New Therapeutic Agents.1 passage
• Aggressive Therapy for Acute Pulmonary Embolism: Systemic Thrombolysis and Catheter-Directed Approaches.1 passage
• Air contaminants associated with potential respiratory effects from unconventional resource development activities.1 passage
• Airway Clearance and Mucoactive Therapies.1 passage
• Airway Inflammation and Inflammatory Biomarkers.1 passage
• Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis.1 passage
• Alveolar Hemorrhage in Vasculitis (Primary and Secondary).1 passage
• Ambient particulate matter air pollution and cardiopulmonary diseases.1 passage
• Amyloid in the Lung.1 passage
• Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit.1 passage
• Antibiotic Resistance in Community-Acquired Pneumonia Pathogens.1 passage
• Antibody-Mediated Rejection and Lung Transplantation.1 passage
• Antifungal Therapy: New and Evolving Therapies.1 passage
• Antiglomerular Basement Membrane Disease.1 passage
• Antineutrophil Cytoplasmic Antibody-Associated Lung Fibrosis.1 passage
• Antivirals for Respiratory Viral Infections: Problems and Prospects.1 passage
• Any Role of High-Dose Vitamin C for Septic Shock in 2021?1 passage
• Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development.1 passage
• Approach to Suspected Acute Pulmonary Embolism: Should We Use Scoring Systems?1 passage
• Artificial Intelligence in the Intensive Care Unit.1 passage
• Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues.1 passage
• Aspergillus-Associated Endophenotypes in Bronchiectasis.1 passage
• Asthma during Pregnancy: Exacerbations, Management, and Health Outcomes for Mother and Infant.1 passage
• Autoimmune Encephalitis in Critical Care: Optimizing Immunosuppression.1 passage
• Automated Blood Pressure Control.1 passage
• Avian Influenza A Viruses: Evolution and Zoonotic Infection.1 passage
• Awake or Sedated: Trends in the Evaluation and Management of Agitation in the Intensive Care Unit.1 passage
• Bacterial Pneumonias in Immunocompromised Patients.1 passage
• Bacterial Respiratory Infections Complicating Human Immunodeficiency Virus.1 passage
• Balance between Hyperinflammation and Immunosuppression in Sepsis.1 passage
• Balancing Altered Calcium Metabolism with Bone Health in Sarcoidosis.1 passage
• Bedside Ultrasound in the Intensive Care Unit: Where Is the Evidence?1 passage
• Benign Central Airway Obstruction.1 passage
• Biologic Therapy and Asthma.1 passage
• Biomarkers of Infection: Are They Useful in the ICU?1 passage
• Biomarkers of World Trade Center Particulate Matter Exposure: Physiology of Distal Airway and Blood Biomarkers that Predict FEV₁ Decline.1 passage
• Blastomycosis.1 passage
• Blood Pressure Management for Acute Ischemic and Hemorrhagic Stroke: The Evidence.1 passage
• Body Position and Ventilator-Associated Pneumonia Prevention.1 passage
• Bringing Emergency Neurology to Ambulances: Mobile Stroke Unit.1 passage
• Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management.1 passage
• Bronchiolitis and Bronchiolar Disorders.1 passage
• Bronchoscopic Lung Volume Reduction in Patients with Severe Emphysema.1 passage
• COVID-19 and Its Implications for Thrombosis and Anticoagulation.1 passage
• Carbapenemase-producing Enterobacteriaceae.1 passage
• Cardiac Sarcoidosis.1 passage
• Catheter-Based Approaches for the Treatment of Acute Pulmonary Embolism.1 passage
• Chest Tube Drainage Devices.1 passage
• Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.2 passages
• Chronic Obstructive Pulmonary Disease and Lung Transplantation.1 passage
• Chronic Obstructive Pulmonary Disease in the Intensive Care Unit: Antibiotic Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations.1 passage
• Chronic Obstructive Pulmonary Disease-Evolving Concepts in Treatment: Advances in Pulmonary Rehabilitation.1 passage
• Chronic obstructive pulmonary disease secondary to household air pollution.1 passage
• Circadian Biology and Its Importance to Intensive Care Unit Care and Outcomes.1 passage
• Clinical Decision-Making in Hypersensitivity Pneumonitis: Diagnosis and Management.1 passage
• Clinical Strategies to Prevent Acute Respiratory Distress Syndrome.1 passage
• Clinical and Radiological Phenotypes and Endotypes.1 passage
• Clinical management of infections caused by Enterobacteriaceae that express extended-spectrum β-lactamase and AmpC enzymes.1 passage
• Clinical updates in cystic fibrosis-related diabetes.1 passage
• Coagulation Pathways, Hemostasis, and Thrombosis in Liver Failure.1 passage
• Coccidioidomycosis: Recent Updates.1 passage
• Colistin: how should it be dosed for the critically ill?1 passage
• Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections.1 passage
• Combined Pulmonary Fibrosis and Emphysema.1 passage
• Common Variable Immunodeficiency and Other Immunodeficiency Syndromes in Bronchiectasis.1 passage
• Community-Acquired Pneumonia in Latin America.1 passage
• Community-Acquired Pneumonia in Sub-Saharan Africa.1 passage
• Community-Acquired Pneumonia in the Asia-Pacific Region.1 passage
• Community-Acquired Respiratory Viruses Post-Lung Transplant.1 passage
• Community-Acquired Respiratory Viruses.1 passage
• Community-acquired Pneumonia: A Global Perspective.1 passage
• Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.1 passage
• Comorbidities and Readmissions in Survivors of Acute Hypercapnic Respiratory Failure.1 passage
• Complication of Community-Acquired Pneumonia (Including Cardiac Complications).1 passage
• Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis.1 passage
• Comprehensive Self-Management Strategies.1 passage
• Computed Tomographic Imaging in Connective Tissue Diseases.1 passage
• Connective Tissue Disease-Associated Interstitial Lung Diseases: Unresolved Issues.1 passage
• Control Measures for Human Respiratory Viral Infection.1 passage
• Controlling the Diffusion of Multidrug-Resistant Organisms in Intensive Care Units.1 passage
• Controlling the Risk Domain in Pediatric Asthma through Personalized Care.1 passage
• Controversies Surrounding Renal Replacement Therapy in the Critically Ill Patient.1 passage
• Controversies in the Management of Life-Threatening Pulmonary Embolism.1 passage
• Controversies in the Management of Severe ARDS: Optimal Ventilator Management and Use of Rescue Therapies.1 passage
• Critical Care Beds and Resource Utilization: Current Trends and Controversies.1 passage
• Critical Care Management of Gastrointestinal Bleeding and Ascites in Liver Failure.1 passage
• Critical Care at the End of Life.1 passage
• Critical Care in Human Immunodeficiency Virus-Infected Patients.1 passage
• Cryptococcosis.1 passage
• Current Approach to Diagnosis and Management of Pulmonary Eosinophilic Syndromes: Eosinophilic Pneumonias, Eosinophilic Granulomatosis with Polyangiitis, and Hypereosinophilic Syndrome.1 passage
• Current Concepts in the Epidemiology, Diagnosis, and Management of Histoplasmosis Syndromes.1 passage
• Current Controversies in Sepsis Management.1 passage
• Cutaneous Sarcoidosis.1 passage
• Cystic Fibrosis Diagnosis in Newborns, Children, and Adults.1 passage
• Cystic Fibrosis: Pathophysiology of Lung Disease.1 passage
• Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning.1 passage
• Decompressive Craniectomy for Malignant Middle Cerebral Artery Stroke.1 passage
• Deconstructing ARDS Variability: Platelet Count, an ARDS Intermediate Phenotype and Novel Mediator of Genetic Effects in ARDS.1 passage
• Defining Success in Lung Transplantation: From Survival to Quality of Life.1 passage
• Definitions, Epidemiology, Clinical Risk Factors, and Health Disparities in Acute Respiratory Distress Syndrome.1 passage
• Determinants and Management of the Post-Pulmonary Embolism Syndrome.1 passage
• Development and Maintenance of a Pleural Disease Service: Role of the "Pleurologist".1 passage
• Diagnosis and Initial Investigation of Bronchiectasis.1 passage
• Diagnosis and Management of Severe Asthma.1 passage
• Diagnosis and Treatment of Candidemia in the Intensive Care Unit.1 passage
• Diagnosis and management of Clostridium difficile infection.1 passage
• Diagnosis of Nontuberculous Mycobacteria Lung Disease.1 passage
• Diagnostic Challenge of Tuberculosis Heterogeneity.1 passage
• Diagnostic Pathology of Lung Cancer.1 passage
• Difficult-to-Treat Antibiotic-Resistant Gram-Negative Pathogens in the Intensive Care Unit: Epidemiology, Outcomes, and Treatment.1 passage
• Diffuse Alveolar Hemorrhage and Pulmonary Vasculitides: Histopathologic Findings.1 passage
• Diffuse Cystic Lung Diseases: Diagnostic Considerations.1 passage
• Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism: Use in Patients with Advanced Renal Impairment, Obesity, or Other Weight-Related Special Populations.1 passage
• Donation after Brain Death versus Donation after Circulatory Death: Lung Donor Management Issues.1 passage
• Early Antimicrobial Therapy for Sepsis: Does Each Hour Really Count?1 passage
• Early Psychological Therapy in Critical Illness.1 passage
• Early Warning/Track-and-Trigger Systems to Detect Deterioration and Improve Outcomes in Hospitalized Patients.1 passage
• Echocardiography in the Risk Assessment of Acute Pulmonary Embolism.1 passage
• Elderly Patients in the Intensive Care Unit.1 passage
• Emergence of Antimicrobial Resistance among Pseudomonas aeruginosa: Implications for Therapy.1 passage
• Emergence of Azole Resistance in Aspergillus.1 passage
• Emerging Concepts in Evidence-Based Asthma Management.1 passage
• Emerging Ethical Challenges in Critical Care for the 21st Century: A Case-Based Discussion.1 passage
• Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia.1 passage
• Emerging Role of Extracorporeal Support in Acute and Acute-on-Chronic Liver Failure: Recent Developments.1 passage
• End-of-Life Issues in Intensive Care Units.1 passage
• Endemic Fungi Presenting as Community-Acquired Pneumonia: A Review.1 passage
• Endocrine Complications of Cystic Fibrosis: A Multisystem Disease of the Endocrine Organs.1 passage
• Enhanced Recovery after Thoracic Surgery.1 passage
• Enterovirus D68 and Human Respiratory Infections.1 passage
• Environmental Causes of Asthma.1 passage
• Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss).1 passage
• Epidemiology of Asthma and Influence of Ethnicity.1 passage
• Epidemiology of Chronic Obstructive Pulmonary Disease: Prevalence, Morbidity, Mortality, and Risk Factors.1 passage
• Epidemiology of HIV-Associated Lung Disease in the United States.1 passage
• Epidemiology of Nontuberculous Mycobacteriosis.1 passage
• Evaluating the Right Ventricle in Acute and Chronic Pulmonary Embolism: Current and Future Considerations.1 passage
• Evaluation and Diagnosis of HIV-Associated Lung Disease.1 passage
• Evidence for the Application of Sepsis Bundles in 2021.1 passage
• Exercise and Asthma.1 passage
• Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant.1 passage
• Extracorporeal Strategies in Acute Respiratory Distress Syndrome.1 passage
• Familial Interstitial Lung Disease.1 passage
• Family-Centered Care in the Intensive CareUnit-What Does Best Practice Tell Us?1 passage
• Fluid Management in Acute Respiratory Distress Syndrome.1 passage
• Fungal Infection in Lung Transplantation.1 passage
• Fungal Infections Complicating Lung Transplantation.1 passage
• Fungal, Viral, and Parasitic Pneumonias Associated with Human Immunodeficiency Virus.1 passage
• Fungi in cystic fibrosis and non-cystic fibrosis bronchiectasis.1 passage
• Fusariosis.1 passage
• Future Directions for Hypothermia following Severe Traumatic Brian Injury.1 passage
• Gastrointestinal and Hepatobiliary Disease in Cystic Fibrosis.1 passage
• Gene-environment interaction from international cohorts: impact on development and evolution of occupational and environmental lung and airway disease.1 passage
• General Care of the Pregnant Patient in the Intensive Care Unit.1 passage
• General Management Principles of the Pregnant Woman.1 passage
• Genetics and Idiopathic Interstitial Pneumonias.1 passage
• Genotypes and phenotypes in cystic fibrosis and cystic fibrosis transmembrane regulator-related disorders.1 passage
• Geographic Distribution of Nontuberculous Mycobacteria Isolated from Clinical Specimens: A Systematic Review.1 passage
• Global Considerations in Human Immunodeficiency Virus-Associated Respiratory Disease.1 passage
• Global Epidemiology of Tuberculosis.1 passage
• Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment.1 passage
• Growth and Nutrition in Cystic Fibrosis.1 passage
• Health-Related Quality of Life in Sarcoidosis.1 passage
• Hemodynamic Monitoring for the Evaluation and Treatment of Shock: What Is the Current State of the Art?1 passage
• Hepatic Sarcoidosis: Current Concepts and Treatments.1 passage
• Hermansky-Pudlak Syndrome.1 passage
• Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes.1 passage
• High-Risk Pulmonary Embolism: Embolectomy and Extracorporeal Membrane Oxygenation.1 passage
• Histology of Pulmonary and Bronchiolar Disorders in Connective Tissue Diseases.1 passage
• Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management.1 passage
• How Antibiotics Stewardship Can Be Safely Implemented in Patients with Septic Shock?1 passage
• How Cool It Is: Targeted Temperature Management for Brain Protection Post-Cardiac Arrest.1 passage
• How Should Lungs Be Allocated for Transplant?1 passage
• How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?1 passage
• How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?1 passage
• Human Immunodeficiency Virus Infection and Host Defense in the Lungs.1 passage
• Human Influenza Virus Infections.1 passage
• Human Respiratory Syncytial Virus: Infection and Pathology.1 passage
• Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy.1 passage
• Ictal-Interictal Continuum: When to Worry About the Continuous Electroencephalography Pattern.1 passage
• Identifying Molecular Targets for New Drug Development for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?1 passage
• Idiopathic Pulmonary Fibrosis: Epidemiology, Clinical Features, Prognosis, and Management.1 passage
• Imaging in Neurocritical Care Practice.1 passage
• Imaging in cystic fibrosis and non-cystic fibrosis bronchiectasis.1 passage
• Immunosuppression: Have We Learnt Anything?1 passage
• Immunotherapy and Radiation Therapy for Non-Small Cell Lung Cancer-A Stimulating Partnership.1 passage
• Immunotherapy for Lung Cancer: No Longer an Abstract Concept.1 passage
• Immunotherapy in Advanced Non-Small Cell Lung Cancer.1 passage
• Improving the Patient Handoff Process in the Intensive Care Unit: Keys to Reducing Errors and Improving Outcomes.1 passage
• Indeterminate Pulmonary Nodules: How to Minimize Harm.1 passage
• Indwelling Pleural Catheter Placement for Nonmalignant Pleural Effusions.1 passage
• Infections Due to Acinetobacter baumannii in the ICU: Treatment Options.1 passage
• Infectious Complications in Critically Ill Liver Failure Patients.1 passage
• Inferior Vena Cava Filters: When to Place and When to Remove.1 passage
• Influenza Infections and Emergent Viral Infections in Intensive Care Unit.1 passage
• Influenza Virus in Community-Acquired Pneumonia: Current Understanding and Knowledge Gaps.1 passage
• Inhaled antibiotics in Cystic Fibrosis (CF) and non-CF bronchiectasis.1 passage
• Innovative ICU Solutions to Prevent and Reduce Delirium and Post-Intensive Care Unit Syndrome.1 passage
• Integrated Multiorgan Bedside Ultrasound for the Diagnosis and Management of Sepsis and Septic Shock.1 passage
• Intensivist Staffing: Evolving Challenges and Solutions.1 passage
• Interstitial Lung Disease in Women of Child-Bearing Age.1 passage
• Interstitial Pneumonia with Autoimmune Features and Undifferentiated Connective Tissue Disease.1 passage
• Interventional Pulmonology: The Role of Simulation Training and Competency-Based Evaluation.1 passage
• Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment.1 passage
• Invasive Candidiasis.1 passage
• Invasive Mechanical Ventilation in Chronic Obstructive Pulmonary Disease Exacerbations.1 passage
• Invasive Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Exacerbations.1 passage
• Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts.1 passage
• Invasive Pulmonary Aspergillosis.1 passage
• Is There a Role for Inhaled Antibiotics in the Treatment of Ventilator-Associated Infections?1 passage
• Kidney Injury and Electrolyte Abnormalities in Liver Failure.1 passage
• Less Is More in the ICU: Resuscitation, Oxygenation and Routine Tests.1 passage
• Life-Threatening Hemoptysis.1 passage
• Linear Endobronchial Ultrasound: What's New?1 passage
• Local Ablative Therapies in Oligometastatic NSCLC: New Data and New Directions.1 passage
• Long-Term Antibiotics in Bronchiectasis.1 passage
• Lung Disease in Antiphospholipid Syndrome.1 passage
• Lung Diseases in Inflammatory Myopathies.1 passage
• Lung Malignancies in HIV Infection.1 passage
• Lung Nodule Management: An Interventional Pulmonology Perspective.1 passage
• Lung Volume Reduction in Pulmonary Emphysema.1 passage
• Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.1 passage
• Lymphangioleiomyomatosis.1 passage
• Lymphoid Interstitial Pneumonia and Other Benign Lymphoid Disorders.1 passage
• Malignant Mesothelioma: Has Anything Changed?1 passage
• Malignant Pleural Effusions: Management Options.1 passage
• Management and Challenges of Severe Traumatic Brain Injury.1 passage
• Management and Prevention of Central Venous Catheter-Related Infections in the ICU.1 passage
• Management of Acute Respiratory Failure in Pregnancy.1 passage
• Management of Asthma during Pregnancy: Optimizing Outcomes and Minimizing Risk.1 passage
• Management of Cerebral Edema in Acute Liver Failure.1 passage
• Management of Extrapulmonary Nontuberculous Mycobacterial Infections.1 passage
• Management of Malignant Pleural Effusions-What Is New.1 passage
• Management of Multidrug-Resistant Tuberculosis.1 passage
• Many Faces of Bronchiolitis and Organizing Pneumonia.1 passage
• Massive Pulmonary Embolism: Extracorporeal Membrane Oxygenation and Surgical Pulmonary Embolectomy.1 passage
• Medical Therapy in Idiopathic Pulmonary Fibrosis.1 passage
• Medical and Surgical Management of Empyema.1 passage
• Melioidosis: A Neglected Cause of Community-Acquired Pneumonia.1 passage
• Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment.1 passage
• Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome.1 passage
• Metabolic Management during Critical Illness: Glycemic Control in the ICU.1 passage
• Metabolic and Endocrine Challenges.1 passage
• Metapneumovirus Infections and Respiratory Complications.1 passage
• Metastatic Lung Cancer: Emerging Therapeutic Strategies.1 passage
• Microbiology of Cystic Fibrosis Airway Disease.1 passage
• Microscopic Polyangiitis: New Insights into Pathogenesis, Clinical Features and Therapy.1 passage
• Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus.1 passage
• Middle East Respiratory Syndrome Virus Pathogenesis.1 passage
• Molecular Diagnostics in Non-Small Cell Lung Carcinoma.1 passage
• Molecular Testing on Pleural Fluid Samples.1 passage
• Mucormycosis.1 passage
• Mucormycosis: New Developments into a Persistently Devastating Infection.1 passage
• Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease.1 passage
• Multimodality Monitoring: Toward Improved Outcomes.1 passage
• Mycobacteria: Selection of Transplant Candidates and Post-lung Transplant Outcomes.1 passage
• Mycobacterial Lung Disease Complicating HIV Infection.1 passage
• Neurocritical Care Management of Hepatic Encephalopathy and Coma in Liver Failure.1 passage
• Neuroprognostication of Cardiac Arrest Patients: Outcomes of Importance.1 passage
• New Developments in Blastomycosis.1 passage
• New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome.1 passage
• New Insights on Pulmonary Paracoccidioidomycosis.1 passage
• New Pharmacotherapeutic Approaches for Chronic Obstructive Pulmonary Disease.1 passage
• New Strategies Targeting Virulence Factors of Staphylococcus aureus and Pseudomonas aeruginosa.1 passage
• Nocardia spp.: A Rare Cause of Pneumonia Globally.1 passage
• Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses.1 passage
• Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?1 passage
• Nonantibiotic Pharmacological Treatment of Severe Chronic Obstructive Pulmonary Disease Exacerbations.1 passage
• Noninfectious and Nonneoplastic Conditions Associated with Human Immunodeficiency Virus Infection.1 passage
• Noninvasive Monitoring in the Intensive Care Unit.1 passage
• Noninvasive Ventilation and High-Flow Nasal Therapy Administration in Chronic Obstructive Pulmonary Disease Exacerbations.1 passage
• Nonlife-Threatening Sarcoidosis.1 passage
• Nonspecific Interstitial Pneumonia.1 passage
• Nonspecific Interstitial Pneumonia: What Is the Optimal Approach to Management?1 passage
• Nontuberculous Mycobacteria in Cystic Fibrosis.2 passages
• Nontuberculous Mycobacteria.1 passage
• Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.1 passage
• Novel Aerosol Delivery Devices.1 passage
• Novel Approaches to Hasten Detection of Pathogens and Antimicrobial Resistance in the Intensive Care Unit.1 passage
• Novel Endoscopic Approaches to Treating Chronic Obstructive Pulmonary Disease and Emphysema.1 passage
• Obstacles to and Solutions for a Successful Lung Cancer Screening Program.1 passage
• Obstetric Disorders in the ICU.1 passage
• Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs.1 passage
• Occupational and environmental bronchiolar disorders.1 passage
• Occupational asthma and work-exacerbated asthma.1 passage
• Ocular Sarcoidosis.1 passage
• Optimal Sedation and Pain Management: A Patient- and Symptom-Oriented Paradigm.1 passage
• Optimal Ventilator Strategies in Acute Respiratory Distress Syndrome.1 passage
• Optimizing Fluid Resuscitation and Preventing Fluid Overload in Patients with Septic Shock.1 passage
• Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy.1 passage
• Organ Transplantation for Cystic Fibrosis.1 passage
• Oropharyngeal Decontamination with Antiseptics to Prevent Ventilator-Associated Pneumonia: Rethinking the Benefits of Chlorhexidine.1 passage
• Other Respiratory Viruses as a Cause of Community-Acquired Pneumonia.1 passage
• Overlap Syndromes in Sarcoidosis: Clinical Features and Outcomes.1 passage
• Overview of Fungal Infections--The Italian Experience.1 passage
• Pain and Delirium in Critical Illness: An Exploration of Key 2018 SCCM PADIS Guideline Evidence Gaps.1 passage
• Palliative Care in Lung Cancer: A Review.1 passage
• Parainfluenza Virus Infection.1 passage
• Pathogenesis of ANCA-Associated Pulmonary Vasculitis.1 passage
• Pathogenesis of Acute Respiratory Distress Syndrome.1 passage
• Pathophysiology and Management of Acute Respiratory Distress Syndrome in Obese Patients.1 passage
• Pathophysiology of Bronchiectasis.1 passage
• Patient-Centered Outcomes in Critical Illness: Will My Patient Be Functionally and Cognitively Intact?1 passage
• Percutaneous Tracheostomy.1 passage
• Perioperative Considerations in Liver Transplantation.1 passage
• Personalized Critical Care Medicine: How Far Away Are We?1 passage
• Phaeohyphomycosis.1 passage
• Pharmacokinetic/Pharmacodynamics-Optimized Antimicrobial Therapy in Patients with Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia.1 passage
• Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit.1 passage
• Physical Therapy and Rehabilitation in Chronic Obstructive Pulmonary Disease Patients Admitted to the Intensive Care Unit.1 passage
• Physical, Cognitive, and Psychological Disability Following Critical Illness: What Is the Risk?1 passage
• Physiologic Basis of Symptoms in Pleural Disease.1 passage
• Pleural Disease in Women.1 passage
• Pleurodesis.1 passage
• Pneumocystis jiroveci.1 passage
• Pneumocystis jirovecii Pneumonia in Human Immunodeficiency Virus Infection.1 passage
• Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease.1 passage
• Pneumothorax-Time for New Guidelines?1 passage
• Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.1 passage
• Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer.1 passage
• Predictors of Maternal Mortality and Prognostic Models in Obstetric Patients.1 passage
• Prevention and Management of Delirium in the Intensive Care Unit.1 passage
• Prevention of Intensive Care Unit-Acquired Pneumonia.1 passage
• Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era.1 passage
• Primary Ciliary Dyskinesia.1 passage
• Primary Graft Dysfunction (PGD) Following Lung Transplantation.1 passage
• Primary Graft Dysfunction.1 passage
• Primary ciliary dyskinesia.1 passage
• Principles of Antibiotic Management of Community-Acquired Pneumonia.1 passage
• Prone Positioning in Acute Respiratory Distress Syndrome.1 passage
• Protocol-Based Care versus Individualized Management of Patients in the Intensive Care Unit.1 passage
• Pseudomonas aeruginosa in Bronchiectasis.1 passage
• Pseudomonas aeruginosa: evolution of antimicrobial resistance and implications for therapy.1 passage
• Pulmonary Alveolar Microlithiasis.1 passage
• Pulmonary Alveolar Proteinosis Syndrome.1 passage
• Pulmonary Coccidioidomycosis.1 passage
• Pulmonary Complications of Cystic Fibrosis.1 passage
• Pulmonary Complications of Pregnancy: Venous Thromboembolism.1 passage
• Pulmonary Complications of Rheumatoid Arthritis.1 passage
• Pulmonary Complications of Systemic Lupus Erythematosus.1 passage
• Pulmonary Cryptococcosis.1 passage
• Pulmonary Embolism in Pregnancy.1 passage
• Pulmonary Hypertension Associated with Connective Tissue Disease.1 passage
• Pulmonary Hypertension in Pregnancy.1 passage
• Pulmonary Infections in Pregnancy.1 passage
• Pulmonary Langerhans Cell Histiocytosis.1 passage
• Pulmonary Sporotrichosis: An Evolving Clinical Paradigm.1 passage
• Pulmonary and Bronchiolar Involvement in Sjogren's Syndrome.1 passage
• Pushing the Envelope for Donor Lungs.1 passage
• Q Fever (Coxiella Burnetii).1 passage
• Radiation Therapy for Stage I Nonoperable or Medically Inoperable Lung Cancer.1 passage
• Radiographic and Histopathologic Features in Sarcoidosis: A Pictorial Display.1 passage
• Recent Advances and Future Needs in Interstitial Lung Diseases.1 passage
• Reconsidering Nutritional Support in Critically Ill Patients.1 passage
• Respiratory Viruses and Asthma.1 passage
• Reversal of Direct Oral Anticoagulants: Current Status and Future Directions.1 passage
• Reversal of Oral Anticoagulants for Intracerebral Hemorrhage Patients: Best Strategies.1 passage
• Risk Stratification for Proven Acute Pulmonary Embolism: What Information Is Needed?1 passage
• Risk Stratification in Acute Pulmonary Embolism: The Latest Algorithms.1 passage
• Role of Atypical Pathogens in the Etiology of Community-Acquired Pneumonia.1 passage
• Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.1 passage
• Role of Pharmacologic Paralysis in Acute Respiratory Distress Syndrome.1 passage
• Role of chest computed tomography in prevention of occupational respiratory disease: review of recent literature.1 passage
• Sarcoidosis-Associated Pulmonary Hypertension.1 passage
• Screening Sarcoidosis Patients for Occult Disease.1 passage
• Selection Criteria for Lung Transplantation: Controversies and New Developments.1 passage
• Selection of Candidates for Lung Transplantation and Controversial Issues.1 passage
• Severity Assessment and the Immediate and Long-Term Prognosis in Community-Acquired Pneumonia.1 passage
• Shock Etiologies and Fluid Management in Liver Failure.1 passage
• Should Vasopressors Be Started Early in Septic Shock?1 passage
• Should We Immediately Start Antibiotics in Every Patient with a Clinical Suspicion of HAP/VAP?1 passage
• Should We Treat Ventilator-Associated Tracheobronchitis with Antibiotics?1 passage
• Skin Cancers and Lung Transplant.1 passage
• Sleep in the Intensive Care Unit: Strategies for Improvement.1 passage
• Small Cell Lung Cancer.1 passage
• Small Cell Lung Cancer: Advances in Diagnosis and Management.1 passage
• Small airways involvement in coal mine dust lung disease.1 passage
• Smoking Cessation in Chronic Obstructive Pulmonary Disease.1 passage
• Spontaneous Intraventricular Hemorrhage: When Should Intraventricular tPA Be Considered?1 passage
• Stage III Non-small Cell Lung Cancer.1 passage
• Staphylococcus aureus Pneumonia in the Community.1 passage
• Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies.1 passage
• Supplemental Oxygen Therapy for Patients with Chronic Obstructive Pulmonary Disease.1 passage
• Surgery as a Component of Multimodality Care for Known Stage IIIA-N2 Non-small Cell Lung Cancer.1 passage
• Surgical Approaches to Treating Emphysema: Lung Volume Reduction Surgery, Bullectomy, and Lung Transplantation.1 passage
• Surgical Management of Pulmonary Mycobacterial Disease.1 passage
• Surgical Treatment of Early l Stage Lung Cancer: What has Changed and What will Change in the Future.1 passage
• Surveillance Bronchoscopy: Is It Still Relevant?1 passage
• Surveillance for occupational respiratory diseases in developing countries.1 passage
• Survival Outcome of Sepsis in Recipients of Solid Organ Transplant.1 passage
• Suspected Acute Pulmonary Embolism: Gestalt, Scoring Systems, and Artificial Intelligence.1 passage
• Sweet Spot: Glucose Control in the Intensive Care Unit.1 passage
• Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview.1 passage
• Systemic Thrombolytic Therapy for Acute Pulmonary Embolism: Who Is a Candidate?1 passage
• Targeted Therapy for Non-Small Cell Lung Cancer.1 passage
• The Assessment of the Right Heart Failure Syndrome.1 passage
• The Burden of Neurosarcoidosis: Essential Approaches to Early Diagnosis and Treatment.1 passage
• The Deteriorating Patient: Therapies Including Lung Transplantation.1 passage
• The Great Masquerader: Tuberculosis Presenting as Community-Acquired Pneumonia.1 passage
• The Human Respiratory Microbiome: Implications and Impact.1 passage
• The Impact of Antiretroviral Therapy on Lung Immunology.1 passage
• The Impact of Resistant Bacterial Pathogens including Pseudomonas aeruginosa and Burkholderia on Lung Transplant Outcomes.1 passage
• The Long and Winding Road to Personalized Glycemic Control in the Intensive Care Unit.1 passage
• The Lung Allocation Score and Its Relevance.1 passage
• The Modern Diagnostic Approach to Community-Acquired Pneumonia in Adults.1 passage
• The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead?1 passage
• The Promise of Observational Studies (ECLIPSE, SPIROMICS, and COPDGene) in Achieving the Goal of Personalized Treatment of Chronic Obstructive Pulmonary Disease.1 passage
• The Pulmonary Embolism Response Team: What Is the Ideal Model?1 passage
• The Pulmonary Embolism Response Team: Why and How?1 passage
• The Pursuit of Noninvasive Diagnosis of Lung Cancer.1 passage
• The Role of Noninvasive Ventilation in the Hospital and Outpatient Management of Chronic Obstructive Pulmonary Disease.1 passage
• The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia.2 passages
• The State of the Science in Patient-Reported Outcomes for Patients with Lung Cancer.1 passage
• The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.1 passage
• Thoracic Involvement in IgG4-Related Disease.1 passage
• Thoracoscopy: Advances and Increasing Role for Interventional Pulmonologists.1 passage
• Thrombophilic Evaluation in Patients with Acute Pulmonary Embolism.1 passage
• To Trach or Not to Trach: Uncertainty in the Care of the Chronically Critically Ill.1 passage
• Tobacco Control and Tobacco Cessation in Lung Cancer-Too Little, Too Late?1 passage
• Too Little Oxygen: Ventilation, Prone Positioning, and Extracorporeal Membrane Oxygenation for Severe Hypoxemia.1 passage
• Too Much Oxygen: Hyperoxia and Oxygen Management in Mechanically Ventilated Patients.1 passage
• Tools of the Trade: Point-of-Care Ultrasonography as a Stethoscope.1 passage
• Tracheobronchomalacia and Excessive Dynamic Airway Collapse: Medical and Surgical Treatment.1 passage
• Transbronchial Cryobiopsies.1 passage
• Translational Research in Intensive Care Unit: Novel Approaches for Drug Development and Personalized Medicine.1 passage
• Treating the Airway Consequences of Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction.1 passage
• Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis.1 passage
• Treatment of Alpha-1 Antitrypsin Deficiency.1 passage
• Treatment of Mycobacterium abscessus Complex.1 passage
• Treatment of Mycobacterium avium Complex (MAC).1 passage
• Treatment of Other Nontuberculous Mycobacteria.1 passage
• Treatment of Pulmonary Vasculitis.1 passage
• Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond.1 passage
• Trends in Mortality of Acute Pulmonary Embolism.1 passage
• Update on Human Rhinovirus and Coronavirus Infections.1 passage
• Update on Lung Cancer Screening.1 passage
• Updates in the Treatment of Active and Latent Tuberculosis.1 passage
• Using Ventilator-Associated Pneumonia Rates as a Health Care Quality Indicator: A Contentious Concept.1 passage
• VATS and Minimally Invasive Resection in Early-Stage NSCLC.1 passage
• Vasopressor Therapy in the Intensive Care Unit.1 passage
• Venous Thromboembolism: Genetics and Thrombophilias.1 passage
• Ventilator-Associated Pneumonia: The Role of Emerging Diagnostic Technologies.1 passage
• Voriconazole: How to Use This Antifungal Agent and What to Expect.1 passage
• What Is the Evidence for Harm of Neuromuscular Blockade and Corticosteroid Use in the Intensive Care Unit?1 passage
• What Is the Role of Steroids for Septic Shock in 2021?1 passage
• What Is the Utility of Measuring Lactate Levels in Patients with Sepsis and Septic Shock?1 passage
• What We Know About the Pathogenesis of Idiopathic Pulmonary Fibrosis.1 passage
• What's the Score? Do Pleural Effusion Clinical Scoring Systems Help in Management of Disease?1 passage
• Which Biomarkers Can Be Used as Diagnostic Tools for Infection in Suspected Sepsis?1 passage
• Who Is Safe to Extubate in the Neuroscience Intensive Care Unit?1 passage
• Who Should Be at the Bedside 24/7: Doctors, Families, Nurses?1 passage